Delivery Order SPE2DB20D1100-SPE2DB24FB6G6
Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,612.52 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Trulicity 1.5 mg/0.5 ml pens. This order was placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,579.29 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Trulicity 4.5 mg/0.5 ml pens. This contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,306.26 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 4.5 mg/0.5 ml pens. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $1,338.75 firm fixed-price Delivery Order contract for the supply of Trulicity 1.5 mg/0.5 ml pens. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,145.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds as the prime contractor, providing a comprehensive range of pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,805.60 contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a brand name medication. The contract is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,322.36 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pen medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,361.75 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,566,087,705 units of Trulicity 0.75 mg/0.5 ml pens. This contract, which has a firm fixed price, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,451.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. This order is placed under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $1,741.68 and a performance period through April 11, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, for delivering pharmaceuticals and medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB6G6Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,169.21 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Trulicity 0.75 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has a firm fixed price and a completion date of May 7, 2024. It was awarded on May 6, 2024, and does not have a set-aside designation.
Generated 8/5/24, 9:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/6/24 |